Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: Synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions

Journal of Medicinal Chemistry

Volumn 40, Issue 1, 1997, Pages 132-136

  Lim, John K ^a   Mathias, Carla J ^a   Green, Mark A ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER 62; COPPER 67; RADIOPHARMACEUTICAL AGENT; THIOSEMICARBAZONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DISTRIBUTION; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; ISOTOPE LABELING; LIGAND BINDING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; TISSUE DISTRIBUTION; TISSUE PERFUSION;

ANIMALS; COPPER; DOGS; HUMANS; RADIOPHARMACEUTICALS; RATS; THIOSEMICARBAZONES; TISSUE DISTRIBUTION; ULTRAFILTRATION;

EID: 0031012934     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9605703     Document Type: Article

References (31)

1. 62Cu-PTSM: A Generator-Based PET Radiopharmaceutical for Myocardial Perfusion Imaging. In Cardiac Positron Emission Tomography; Schwaiger, M., Ed.; Kluwer Academic Publishers: Boston, 1996; pp 161-172.
2. 4-methylthiosemicarbazonato) Copper-(II): Synthesis And Evaluation As A Positron Emission Tomography Tracer For Cerebral And Myoeardial Perfusion. J. Nucl. Med. 1990, 31, 1989-1996.
3. (a) Shelton, M. E.; Green, M. A.; Mathias, C. J.; Welch, M. J.; Bergmann, S. R. Assessment of Regional Myocardial and Renal Blood Flow Using Copper-PTSM and Positron Emission Tomography. Circulation 1990, 82, 990-997.
4. 62Cu-PTSM and Positron Emission Tomography. Circulation 1993, 87, 173-183.
5. (a) Bergmann, S. R.; Herrero, P.; Hartman, J. J.; Anderson, C. J.; Welch, M. J.; Green, M. A. Use and Limitations of Copper-62 Pyruvaldehyde Bis(methylthiosemicarbazone) and Positron Emission Tomography for Measuring Regional Myocardial Perfusion in Human Subjects. Circulation 1993, 88, 171 (abstract).
6. 62Cu-PTSM and PET in Human Subjects. J. Nucl. Med. 1996, 37, 1294-1300.
7. Beanlands, R. S.; Muzik, O.; Mintun, M. A.; Mangner, T.; Lee, K.; Petry, N. ; Hutchins, G. D.; Schwaiger, M. The Kinetics of Copper-62-PTSM in the Normal Human Heart. J. Nucl. Med. 1992, 33, 684-690.
8. Melon, P. G.; Brihaye, C.; Degueldre, C.; Guillaume, M.; Czichosz, R.; Rigo, P.; Kulbertus, H.; Comar, D. Myocardial Kinetics of Potassium-38 in Humans and Comparison with Copper-62-PTSM. J. Nucl. Med. 1994, 35, 1116-1122.
9. Beanlands, R. S. B.; Muzik, O.; Hutchins, G. D.; Woulfe, E. R.; Schwaiger, M. Heterogeneity of Regional Nitrogen-13-Labeled Ammonia Tracer Distribution in the Normal Human Heart: Comparison with Rubidium-82 and Copper-62-Labeled PTSM. J. Nucl. Cardiol. 1994, 1, 225-235.
10. Tadamura, E.; Tamaki, N.; Okazawa, H.; Fujibayashi, Y.; Kudoh, T.; Yonekura, Y.; Magata, Y.; Nohara, R.; Sasayama, S.; Konishi, J. Generator-Produced Copper-62-PTSM as a Myocardial PET Perfusion Tracer Compared with Nitrogen-13-Ammonia. J. Nucl. Med. 1996, 37, 729-735.
11. (a) Okazawa, H.; Yonekura, Y.; Fujibayashi, Y.; Nishizawa, S.; Magata, Y.; Ishizu, K.; Tanaka, F.; Tsuchida, T.; Tamaki, N.; Konishi, J. Clinical Application and Quantitative Evaluation of Generator-Produced Copper-62-PTSM as a Brain Perfusion Tracer for PET. J. Nucl. Med. 1994, 35, 1910-1915.
12. (b) Okazawa, H.; Yonekura, Y.; Fujibayashi, Y.; Mukai, T.; Nishizawa, S.; Magata, Y.; Ishizu, K.; Tamaki, N.; Konishi, J. Measurement of Regional Cerebral Blood Flow with Copper-62-PTSM and a Three-Compartment Model. J. Nucl. Med. 1996, 37, 1089-1093.
13. 4-methylthiosemicarbazone) for Tissue Blood Flow Measurements Using a Trapped Tracer Model. Eur. J. Nucl. Med. 1994, 21, 336-341.
14. Mathias, C. J.; Bergmann, S. R.; Green, M. A. Development and Validation of a Solvent Extraction Technique for Determination of Cu-PTSM in Blood. Nucl. Med. Biol. 1993, 20, 343-349.
15. Mathias, C. J.; Bergmann, S. R.; Green, M. A. Species-Dependent Binding of Copper(II) Bis(thiosemicarbazone) Radiopharmaceuticals to Serum Albumin. J. Nucl. Med. 1995, 36, 1451-1455.
16. John, E.; Green, M. A. Structure-Activity Relationships for Metal-Labeled Blood Flow Tracers: Comparison of Ketoaldehyde Bis(thiosemicarbazonato)copper(II) Derivatives. J. Med. Chem. 1990, 33, 1764-1770.
17. Mathias, C. J.; Welch, M. J.; Raichle, M. E.; et al. Evaluation of a Potential Generator-Produced PET Tracer for Cerebral Perfusion Imaging: Single-Pass Cerebral Extraction Measurements and Imaging with Radiolabeled Cu-PTSM. J. Nucl. Med. 1990, 37, 351-359.
18. (a) Minkel, D. T.; Saryan, L. A.; Petering, D. H. Structure-Function Correlations in the Reaction of Bis(thiosemicarbazone) Copper(II) Complexes with Ehrlich Acites Tumor Cells. Cancer Res. 1978, 38, 124-129.
19. (b) Winkelmann, D. A.; Bermke, Y.; Petering, D. H. Comparative Properties of the Antineoplastic Agent 3-ethoxy-2-oxobutyraldehyde Bis(thiosemicarbazone) Copper(II) and Related Chelates: Linear Free Energy Relationships. Bioinorg. Chem. 1974, 3, 261-277.
20. (a) Barry, C.; Conalty, M. L.; O'Sullivan, J. F. Anticancer Activity of Bisthiosemicarbazones of Methylglyoxal. Cancer Res. 1966, 26, 2165-2168.
21. (b) Barry, V. C.; Byrne, J.; Conalty, M. L.; O'Sullivan, J. F. Anticancer agents - II Synthesis and Antimycobacterial Activity of Some Novel Methylglyoxal Derivatives. Proc. R. Ir. Acad. 1967, 65, 269-284.
22. (c) Barry, V. C.; Conalty, M. L.; O'Callaghan, C. N.; Twomey, D. Anticancer Agents - III Synthesis and Anticancer Activity of Some Bis(thiosemicarbazones) and Thiosemicarbazides. Proc. R. Ir. Acad. 1967, 65, 309-324.
23. 67Cu complexes of 4a, 4b, 4c, and 4d, respectively.
24. Shelton, M. E.; Green, M. A.; Mathias, C. J.; Welch, M. J.; Bergmann, S. R. Kinetics of Copper-PTSM in Isolated Hearts: A Novel Tracer for Measuring Blood Flow with Positron Emission Tomography. J. Nucl. Med. 1989, 30, 1843-1847.
25. 4-methylthiosemicarbazone) (Cu-PTSM) by Brain and Tumor: A Novel Radiopharmaceutical for Positron Emission Tomography Imaging. Ann. Nucl. Med. 1995, 9, 1-5.
26. 4-methylthiosemicarbazone) (Cu-PTSM), a Metal Complex with B Selective NADH-Dependent Reduction by Complex I in Brain Mitochondria: A Potential Radiopharmaceutical for Mitochondria-Function Imaging with Positron Emission Tomography (PET). Biol. Pharm. Bull. 1995, 18, 1126-1129.
27. 67Cu-Labeled Cu-PTSM. Nucl. Med. Biol. 1992, 19, 697-701.
28. 3).
29. 3).
30. 2O) C, H, N.
31. Bates, R. G.; Vega, C. A.; White, D. R. Standards for pH Measurements in Isotonic Saline Media of Ionic Strength I=0.16. Anal. Chem. 1978, 50, 1295-1300.